European Medicines Verification Organisation
European Medicines Verification Organisation (EMVO) is a Belgian non-profit that operates the European Medicines Verification System, a mandated EU-wide IT platform connecting 29 countries' national systems to detect falsified medicines across the pharmaceutical supply chain.
- Company typePrivate
- Founded2015
- HeadquartersBrussels, Belgium
- Headcount11–50
- GTM typeB2B
- OfferingSoftware
What European Medicines Verification Organisation does
European Medicines Verification Organisation (EMVO) is a Belgian non-profit association (EMVO asbl), founded in 2015 and headquartered in Brussels, that operates the European Medicines Verification System (EMVS), a pan-European IT platform mandated by EU Directive 2011/62/EU (the Falsified Medicines Directive). EMVO's core function is to operate the central European Hub, which connects national medicine verification systems across 29 participating countries, providing secure data flow for end-to-end verification of prescription medicines to prevent falsified products from entering the legal supply chain. The platform serves 2,900+ marketing authorisation holders, 4,000+ wholesale distribution authorisation holders, 115,000+ commercial pharmacies, and 6,000+ hospital pharmacies.
The product surface spans five components: the European Hub (central infrastructure), the OBP Portal (onboarding and product data management for marketing authorisation holders, currently at v5.0.0), the EVI Subscription (a recurring intelligence and analytics service), a Scanner Tool (point-of-dispensing verification), and the European Alert Management System (coordination of suspected-falsification alerts). Recent releases include EU Hub Release 1.20 with mandatory schema upgrades and OBP Portal 5.0.0 with enhanced data visibility and issue tracking.
EMVO is funded through membership and subscription fees from its founding stakeholders (EFPIA, Medicines for Europe, PGEU, GIRP, Affordable Medicines Europe) and affiliate stakeholders (EAHP, HOPE), with a stakeholder-led governance model collectively representing pharmaceutical manufacturers, generic and biosimilar producers, community pharmacists, wholesalers, parallel distributors, hospital pharmacists, and hospital federations. GTM is stakeholder-led and event-driven, anchored by the annual EMVS Forum, professional website and helpdesk channels, and ongoing schema/platform rollouts. Headcount is small (11–50), consistent with a lean operator relying on its multi-stakeholder governance rather than commercial scale.
European Medicines Verification Organisation firmographics
Firmographics- Name
- European Medicines Verification Organisation
- Legal name
- EMVO asbl
- Website
- https://emvo-medicines.eu
- Company type
- Private
- Founded year
- 2015
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- European Medicines Verification Organisation (EMVO) is a Belgian non-profit that operates the European Medicines Verification System, a mandated EU-wide IT platform connecting 29 countries' national systems to detect falsified medicines across the pharmaceutical supply chain.
- Ownership category
- akta.pro rank
European Medicines Verification Organisation industry classification
Industry- Product category
- Pharmaceutical Supply Chain Verification
- NAICS
- Medical and Diagnostic Laboratories (62151), Computer Facilities Management Services (541513)
- SIC
- Services-Computer Programming, Data Processing, Etc. (7370), Services-Testing Laboratories (8734)
- akta.pro primary industry
- Health, Pharmaceuticals & Medical Devices Regulatory Cooperation (BPADANAJ)
- akta.pro secondary industries
- Controlled Substance ePrescribing (EPCS), Diversion Monitoring & Compliance (HLACAKAJ), Medical Device Regulators (HLAJADAC)
Keywords
Where European Medicines Verification Organisation is headquartered
LocationHeadquarters
- HQ city
- Brussels
- HQ country
- Belgium
- HQ region
- Europe
Offices1 record
Markets served
European Medicines Verification Organisation business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Technology or R&D, Operations, Personnel, Infrastructure, Others
Revenue model
- Membership/Subscription fees: EMVO operates as a Belgian non-profit organisation representing stakeholders united in securing the legal supply chain. Revenue appears to come from membership fees from founding and affiliate stakeholders including EFPIA, Medicines for Europe, PGEU, GIRP, and Affordable Medicines Europe.
Go-to-market motion2 records
Distribution channels1 record
Marketing channels5 records
European Medicines Verification Organisation product offering
Product offeringCore offering
EMVO operates the European Medicines Verification System (EMVS), a pan-European IT platform that connects the national medicine verification systems of 29 countries to a central European Hub, enabling end-to-end verification of medicines and secure data management to prevent falsified medicines from entering the legal supply chain. The system is mandated by the EU Falsified Medicines Directive (2011/62/EU) and serves pharmaceutical companies, wholesale distributors, and pharmacies across Europe.
Product overview
EMVO operates the European Medicines Verification System (EMVS), a pan-European IT platform for ensuring medicine authenticity through end-to-end verification and secure data management. The system connects 29 national medicine verification systems to a central European Hub. The portfolio includes the OBP Portal for pharmaceutical company onboarding and data management, the EVI Subscription service for verification intelligence, a Scanner Tool for dispensing point verification, and the European Alert Management System. EMVS connects over 2,900 Marketing Authorisation Holders, 4,000+ Wholesale Distribution Authorisation Holders, 115,000+ Commercial pharmacies, and 6,000+ Hospital pharmacies across Europe.
Differentiator
Problem solved
Functional benefit
Products and services
- European Medicines Verification System (EMVS) A pan-European IT system that ensures medicine authenticity through end-to-end verification and secure data management, connecting the national medicine verification systems of 29 countries to the central European Hub. It serves pharmaceutical companies, wholesale distributors, and pharmacies across Europe.
- OBP Portal Online portal for Marketing Authorisation Holders (MAHs) and other On-boarding Partners to register, upload product master data, manage their connection to the EMVS, and monitor system transactions. Version 5.0.0 offers improved data visibility and validation, enhanced issue tracking, and better usability.
- EVI Subscription
Quantifiable outcome
- 29 countries connected to the European Medicines Verification System
- +2 more outcomes
Companies that use European Medicines Verification Organisation
Customer profileNamed customers4 records
Segments4 records
Ideal customer profiles4 records
European Medicines Verification Organisation technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature6 records
European Medicines Verification Organisation partnerships and signals
Strategic signalPartnerships
Seven partnerships are on record, tiered core and secondary.
- EFPIA (European Federation of Pharmaceutical Industries and Associations)coreEFPIA is a founding stakeholder of EMVO, representing the research-based pharmaceutical industry in Europe. As a founding stakeholder, EFPIA plays a governance role in EMVO's strategic direction and operations.
- Medicines for Europe (European Generic and Biosimilar Medicines Association)coreMedicines for Europe is a founding stakeholder of EMVO, representing generic and biosimilar medicines manufacturers. Contributes to governance and strategic direction as a founding member.
- PGEU (Pharmaceutical Group of the European Union)corePGEU is a founding stakeholder representing community pharmacists at EU level. Plays a governance role in EMVO as a founding member organisation.
- GIRP (European Healthcare Distribution Association)coreGIRP is a founding stakeholder representing pharmaceutical wholesale distribution in Europe. Contributes to EMVO governance as a founding member.
- Affordable Medicines EuropecoreAffordable Medicines Europe is a founding stakeholder representing parallel distribution companies. Serves as a founding member with governance responsibilities.
- EAHP (European Association of Hospital Pharmacists)secondaryEAHP is an affiliate stakeholder of EMVO, representing hospital pharmacists across Europe. Provides input on hospital pharmacy perspectives and practices.
- HOPE (European Hospital and Healthcare Federation)secondaryHOPE is an affiliate stakeholder of EMVO, representing hospitals and healthcare at EU level. Contributes healthcare system perspectives to EMVO activities.
Scale indicators7 records
Recent moves4 records
Expansion highlights4 records
European Medicines Verification Organisation competitors and assessment
Company assessmentBroad incumbents
- European Medicines Agency (EMA): EMA is the EU's regulatory agency overseeing medicines authorisation and pharmacovigilance. Comparable as a peer within the same healthcare regulatory governance ecosystem in which EMVO operates, though with a broader regulatory remit rather than the serialisation focus.
- SAP (Advanced Track and Trace for Pharmaceuticals / ATTP): SAP's ATTP is a major commercial pharmaceutical serialisation platform used by manufacturers to comply with track-and-trace mandates globally. Comparable as a commercial supplier working within or alongside regulatory verification regimes analogous to EMVS.
Others
- RxBenefits / MarkVision (Pharma Supply Chain IT): Adjacent pharma supply-chain IT and data analytics providers serving manufacturers and pharmacies with compliance and dispensing solutions. Comparable as ecosystem participants building tooling that interacts with EMVS endpoints at the dispensing or supply-chain node.
Direct peers
- securPharm (Germany NMVO): securPharm operates the German national medicines verification system (national blueprint of the FMD), directly connected to and governed with EMVO via the European Hub. It is the clearest direct functional peer, sharing the same regulatory regime and verification model at the national level.
- NMVO Italia: Italy's NMVO operates the national verification system connected to EMVO and is referenced by EMVO in onboarding communications. Functionally and structurally a direct national-level peer.
- Medicine Verification (France): France-MVO runs the French national medicines verification system under the same EU FMD framework, interoperating with EMVO's European Hub. Directly comparable as a national-level operator within EMVO's stakeholder network.
Emerging players
- TraceLink: TraceLink is a leading commercial pharmaceutical serialisation and track-and-trace platform serving DSCSA (US) and other markets. Comparable as a competing/implementation-level provider in pharmaceutical supply-chain verification, although built on a commercial SaaS model rather than an EU-mandated non-profit model.
- Movilitas Consulting: Movilitas provides regulatory compliance and serialisation consulting/technology for the pharmaceutical supply chain (FMD, DSCSA). Comparable as an adjacent implementation and compliance services peer operating in the same regulatory ecosystem.
- OPTEL Group: OPTEL offers traceability, serialisation, and supply-chain transparency solutions for pharmaceuticals, including FMD compliance tooling. Comparable as an emerging player providing competing/parallel verification capability at the supplier level.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat5 records
Key risks5 records
Key highlights6 records
Customer concentration
European Medicines Verification Organisation social profiles
Digital presenceEuropean Medicines Verification Organisation financial estimates
Financial estimateRevenue estimate
Valuation estimate
European Medicines Verification Organisation leadership team
Management profileNumber of profiles
Profiles7 records
European Medicines Verification Organisation funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
European Medicines Verification Organisation M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about European Medicines Verification Organisation
What does European Medicines Verification Organisation do?
EMVO operates the European Medicines Verification System (EMVS), a pan-European IT platform that connects the national medicine verification systems of 29 countries to a central European Hub, enabling end-to-end verification of medicines and secure data management to prevent falsified medicines from entering the legal supply chain. The system is mandated by the EU Falsified Medicines Directive (2011/62/EU) and serves pharmaceutical companies, wholesale distributors, and pharmacies across Europe.
Is European Medicines Verification Organisation a public or private company?
European Medicines Verification Organisation is a private company. It is classified as nonprofit foundation owned and is currently operating.
When was European Medicines Verification Organisation founded?
European Medicines Verification Organisation was founded in 2015. It employs 11 to 50 people.
Where is European Medicines Verification Organisation based?
European Medicines Verification Organisation is headquartered in Brussels, Belgium, in the Europe region.
How does European Medicines Verification Organisation make money?
One revenue line is on record: membership/Subscription fees.
Who are European Medicines Verification Organisation's main competitors?
Broad incumbents on record are European Medicines Agency (EMA) and SAP (Advanced Track and Trace for Pharmaceuticals / ATTP). RxBenefits / MarkVision (Pharma Supply Chain IT) is listed as an others. Direct peers are securPharm (Germany NMVO), NMVO Italia and Medicine Verification (France). Emerging players are TraceLink, Movilitas Consulting and OPTEL Group.
Does European Medicines Verification Organisation have an API?
No public API is recorded for European Medicines Verification Organisation.
What industry is European Medicines Verification Organisation in?
European Medicines Verification Organisation's product category is Pharmaceutical Supply Chain Verification. Its primary akta.pro industry code is BPADANAJ, Health, Pharmaceuticals & Medical Devices Regulatory Cooperation, with a secondary code of HLACAKAJ, Controlled Substance ePrescribing (EPCS), Diversion Monitoring & Compliance. Its NAICS code is 62151 and its SIC code is 7370.